With reference to the BioE3 policy and BRIC-CDFD, consider the following statements: 1. Ullas Kolthur-Seetharam is the Director of the Department of Biotechnology. 2. The workshop focused on the transition from research to reach in biotechnology. 3. The BioE3 policy was discussed by the Department of Biotechnology. Which of the statements given above is/are correct?

BRIC-CDFD hosts national workshop on BioE3 policy and "From Research to Reach"

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims· 12 October 2026

Translational research and biotechnology policy: a relevant GS3 Science & Technology topic.

Why in news

The BRIC-Centre for DNA Fingerprinting and Diagnostics (BRIC-CDFD) hosted a national workshop to discuss the BioE3 policy and the transition 'From Research to Reach' in biotechnology.

Background

The workshop was held on October 12, 2026, featuring representatives from the Department of Biotechnology. It focused on the BioE3 policy and the translation of research into accessible reach.

Facts for Prelims

BodyBRIC-CDFD: BRIC-Centre for DNA Fingerprinting and Diagnostics
S&TBioE3: A policy framework discussed by the Department of Biotechnology
PostUllas Kolthur-Seetharam: Director of BRIC-CDFD

Prelims practice question

With reference to the BioE3 policy and BRIC-CDFD, consider the following statements:

Ullas Kolthur-Seetharam is the Director of the Department of Biotechnology.
The workshop focused on the transition from research to reach in biotechnology.
The BioE3 policy was discussed by the Department of Biotechnology.

Which of the statements given above is/are correct?

(a)2 only
(b)3 only
(c)1 and 3 only
(d)2 and 3 only

Show answer

Answer: (d) 2 and 3 only — Statements 2 and 3 are correct. Statement 1 is incorrect: He is the Director of BRIC-CDFD.

For Mains

Q. Discuss the significance of the BioE3 policy in bridging the gap between laboratory research and large-scale public accessibility in India's biotechnology sector.

Dimensions to cover in your answer

Translational gap: Challenges in moving from laboratory-scale breakthroughs to commercially viable and accessible public health solutions
Policy framework: Role of Department of Biotechnology in standardizing research-to-reach pathways for indigenous biotech innovations

Keywords: Translational Research · Biotechnology Policy · BioE3 · Public Health Accessibility · Research Commercialization

Read the full news →Report a mistake in this note Source: The Hindu ↗Also: GS2 · Government policies & schemes

More Science & Technology notes

Microsoft's Brad Smith urges U.K. to lead global AI safety rules with kill-switches · 12 October 2026
Delhi government launches DURGA E-Auto Scheme to provide 1,300 electric autos · 11 October 2026
TRISHNA satellite to launch in 12-16 months to monitor water resources and temperature · 11 October 2026
Lancet Commission identifies 17 threats including nuclear war and AI risking human extinction · 11 October 2026
CERN to upgrade Large Hadron Collider to increase collision rates 10 times · 11 October 2026
The Kerala High Court Division Bench of Chief Justice Soumen Sen and Justice V.M · 11 October 2026

All Science & Technology current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.